A citation-based method for searching scientific literature

Max Mimpen, Anne-Hilde Muris, Linda Rolf, Oliver Gerlach, Jens Kuhle, Raymond Hupperts, Joost Smolders, Jan Damoiseaux. Eur J Neurol 2021
Times Cited: 6







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Natural killer cells in multiple sclerosis: A review.
Max Mimpen, Joost Smolders, Raymond Hupperts, Jan Damoiseaux. Immunol Lett 2020
24
66

Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
Wendy Gilmore, Brett T Lund, Peili Li, Alex M Levy, Eve E Kelland, Omid Akbari, Susan Groshen, Steven Yong Cen, Daniel Pelletier, Leslie P Weiner,[...]. J Neuroinflammation 2020
22
66

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.
Catharina C Gross, Andreas Schulte-Mecklenbeck, Heinz Wiendl, Emanuela Marcenaro, Nicole Kerlero de Rosbo, Antonio Uccelli, Alice Laroni. Front Immunol 2016
63
50


Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Alice Laroni, Eric Armentani, Nicole Kerlero de Rosbo, Federico Ivaldi, Emanuela Marcenaro, Simona Sivori, Roopali Gandhi, Howard L Weiner, Alessandro Moretta, Giovanni L Mancardi,[...]. J Autoimmun 2016
63
50

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Bibiana Bielekova, Marta Catalfamo, Susan Reichert-Scrivner, Amy Packer, Magdalena Cerna, Thomas A Waldmann, Henry McFarland, Pierre A Henkart, Roland Martin. Proc Natl Acad Sci U S A 2006
451
50

Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Catharina C Gross, Andreas Schulte-Mecklenbeck, Anna Rünzi, Tanja Kuhlmann, Anita Posevitz-Fejfár, Nicholas Schwab, Tilman Schneider-Hohendorf, Sebastian Herich, Kathrin Held, Matea Konjević,[...]. Proc Natl Acad Sci U S A 2016
112
50

Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.
Qiang Liu, Nader Sanai, Wei-Na Jin, Antonio La Cava, Luc Van Kaer, Fu-Dong Shi. Nat Neurosci 2016
75
33

NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.
Roberto Spada, José M Rojas, Sonia Pérez-Yagüe, Vladimir Mulens, Pablo Cannata-Ortiz, Rafael Bragado, Domingo F Barber. J Leukoc Biol 2015
36
33

KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.
P P Banerjee, L Pang, S S Soldan, S M Miah, A Eisenberg, S Maru, A Waldman, E A Smith, Y Rosenberg-Hasson, D Hirschberg,[...]. Mol Immunol 2019
6
33

Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells.
Zhi-Bin Zhao, Fang-Ting Lu, Hong-Di Ma, Yin-Hu Wang, Wei Yang, Jie Long, Qi Miao, Weici Zhang, Zhigang Tian, William M Ridgway,[...]. Cell Mol Immunol 2020
19
33

The Broad Spectrum of Human Natural Killer Cell Diversity.
Aharon G Freud, Bethany L Mundy-Bosse, Jianhua Yu, Michael A Caligiuri. Immunity 2017
337
33

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
Natasja Nielsen, Veronique Pascal, Andreas E R Fasth, Yvonne Sundström, Elisabeth D Galsgaard, David Ahern, Martin Andersen, Bo Baslund, Else M Bartels, Henning Bliddal,[...]. Immunology 2014
28
33

CD56bright natural killer (NK) cells: an important NK cell subset.
Aurélie Poli, Tatiana Michel, Maud Thérésine, Emmanuel Andrès, François Hentges, Jacques Zimmer. Immunology 2009
530
33

Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.
Luc Van Kaer, Joshua L Postoak, Chuan Wang, Guan Yang, Lan Wu. Cell Mol Immunol 2019
53
33

NK cells in autoimmune diseases: Linking innate and adaptive immune responses.
Elena Gianchecchi, Domenico Vittorio Delfino, Alessandra Fierabracci. Autoimmun Rev 2018
75
33

NK Cells Regulate CD8+ T Cell Mediated Autoimmunity.
Philipp A Lang, Sarah Q Crome, Haifeng C Xu, Karl S Lang, Laurence Chapatte, Elissa K Deenick, Melanie Grusdat, Aleksandra A Pandyra, Vitaly I Pozdeev, Ruifeng Wang,[...]. Front Cell Infect Microbiol 2020
11
33

NK cell subsets in autoimmune diseases.
Cai Zhang, Zhigang Tian. J Autoimmun 2017
31
33

TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity.
Iona S Schuster, Matthew E Wikstrom, Geraldine Brizard, Jerome D Coudert, Marie J Estcourt, Mitali Manzur, Lorraine A O'Reilly, Mark J Smyth, Joseph A Trapani, Geoffrey R Hill,[...]. Immunity 2014
124
33

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.
DeRen Huang, Fu-Dong Shi, Steffen Jung, Gary C Pien, Jintang Wang, Thais P Salazar-Mather, Toby T He, Jennifer T Weaver, Hans-Gustaf Ljunggren, Christine A Biron,[...]. FASEB J 2006
209
33

The Increased Ratio of Blood CD56bright NK to CD56dim NK Is a Distinguishing Feature of Primary Sjögren's Syndrome.
Bingxia Ming, Tong Wu, Shaozhe Cai, Peng Hu, Jungen Tang, Fang Zheng, Cong Ye, Lingli Dong. J Immunol Res 2020
9
33

Multiple sclerosis.
Massimo Filippi, Amit Bar-Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A Rocca. Nat Rev Dis Primers 2018
474
33

Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis.
E Rodríguez-Martín, C Picón, L Costa-Frossard, R Alenda, S Sainz de la Maza, E Roldán, M Espiño, L M Villar, J C Álvarez-Cermeño. Clin Exp Immunol 2015
40
33

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
Peter J Darlington, Brandon Stopnicki, Tarik Touil, Jean-Sebastien Doucet, Lama Fawaz, Morgan E Roberts, Marie-Noëlle Boivin, Nathalie Arbour, Mark S Freedman, Harold L Atkins,[...]. Front Immunol 2018
37
33

NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis.
Max Mimpen, Linda Rolf, Anne-Hilde Muris, Oliver Gerlach, Geert Poelmans, Raymond Hupperts, Joost Smolders, Jan Damoiseaux. J Neuroimmunol 2021
3
66

Multiple sclerosis - a review.
R Dobson, G Giovannoni. Eur J Neurol 2019
495
33

Defective CD19+CD24hiCD38hi transitional B-cell function in patients with relapsing-remitting MS.
Maria T Cencioni, Rehiana Ali, Richard Nicholas, Paolo A Muraro. Mult Scler 2021
14
33

A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis.
Eoin F McKinney, Iona Cuthbertson, Kristina M Harris, Dawn E Smilek, Christopher Connor, Giulia Manferrari, Edward J Carr, Scott S Zamvil, Kenneth G C Smith. Nat Commun 2021
13
33

Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Catharina C Gross, Diana Ahmetspahic, Tobias Ruck, Andreas Schulte-Mecklenbeck, Kathrin Schwarte, Silke Jörgens, Stefanie Scheu, Susanne Windhagen, Bettina Graefe, Nico Melzer,[...]. Neurol Neuroimmunol Neuroinflamm 2016
72
33

Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
Jose E Martínez-Rodríguez, Alvaro Cobo-Calvo, Luisa M Villar, Elvira Munteis, Yolanda Blanco, Raquel Rasal, Andrea Vera, Aura Muntasell, Roberto Alvarez-Lafuente, Albert Saiz,[...]. Mult Scler 2016
16
33

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Stephen Sawcer, Garrett Hellenthal, Matti Pirinen, Chris C A Spencer, Nikolaos A Patsopoulos, Loukas Moutsianas, Alexander Dilthey, Zhan Su, Colin Freeman, Sarah E Hunt,[...]. Nature 2011
33

Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis.
Wenzheng Jiang, Noo Ri Chai, Dragan Maric, Bibiana Bielekova. J Immunol 2011
100
33

An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells.
Jayne F Martin, Justin S A Perry, Neha R Jakhete, Xiang Wang, Bibiana Bielekova. J Immunol 2010
99
33

Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity.
Mayuka Horikawa, Minoru Hasegawa, Kazuhiro Komura, Ikuko Hayakawa, Koichi Yanaba, Takashi Matsushita, Kazuhiko Takehara, Shinichi Sato. J Invest Dermatol 2005
51
16

Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
Paulina Chalan, Johan Bijzet, Bart-Jan Kroesen, Annemieke M H Boots, Elisabeth Brouwer. J Rheumatol 2016
21
16

Autoreactive T cells in type 1 diabetes.
Alberto Pugliese. J Clin Invest 2017
176
16

IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis.
Jinling Huang, Qing Yuan, Hui Zhu, Lan Yin, Shanjuan Hong, Zhongjun Dong, Wei Jin, Chen Dong. J Immunol 2017
20
16

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
Tom H Karlsen, Kirsten Muri Boberg, Marita Olsson, Ji-Yao Sun, David Senitzer, Annika Bergquist, Erik Schrumpf, Erik Thorsby, Benedicte A Lie. J Hepatol 2007
68
16


Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis.
Yan Liang, Zaixing Yang, Chang Li, Ye Zhu, Lingzhen Zhang, Renqian Zhong. Clin Exp Med 2008
20
16

The activating receptor NKp46 is essential for the development of type 1 diabetes.
Chamutal Gur, Angel Porgador, Moran Elboim, Roi Gazit, Saar Mizrahi, Noam Stern-Ginossar, Hagit Achdout, Hormas Ghadially, Yuval Dor, Tomer Nir,[...]. Nat Immunol 2010
140
16

Liver-Derived TGF-β Maintains the EomeshiTbetlo Phenotype of Liver Resident Natural Killer Cells.
Cathal Harmon, Gráinne Jameson, Dalal Almuaili, Diarmaid D Houlihan, Emir Hoti, Justin Geoghegan, Mark W Robinson, Cliona O'Farrelly. Front Immunol 2019
11
16

Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody.
Francisco Victorino, Dorothy K Sojka, Kelley S Brodsky, Eoin N McNamee, Joanne C Masterson, Dirk Homann, Wayne M Yokoyama, Holger K Eltzschig, Eric T Clambey. J Immunol 2015
81
16

Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population.
Nicole Marquardt, Esther Wilk, Claudia Pokoyski, Reinhold E Schmidt, Roland Jacobs. Eur J Immunol 2010
47
16

Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.
Simona Sivori, Paola Vacca, Genny Del Zotto, Enrico Munari, Maria Cristina Mingari, Lorenzo Moretta. Cell Mol Immunol 2019
195
16

Diversity of tissue-resident NK cells.
Hui Peng, Zhigang Tian. Semin Immunol 2017
72
16

Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.
L van Bon, C Popa, R Huijbens, M Vonk, M York, R Simms, R Hesselstrand, D M Wuttge, R Lafyatis, T R D J Radstake. Ann Rheum Dis 2010
48
16

B cells in type 1 diabetes mellitus and diabetic kidney disease.
Mia J Smith, Kimber M Simmons, John C Cambier. Nat Rev Nephrol 2017
58
16

Increased Serum Interleukin-2 Levels Are Associated with Abnormal Peripheral Blood Natural Killer Cell Levels in Patients with Active Rheumatoid Arthritis.
Baochen Li, Qiaoling Guo, Yanyan Wang, Rui Su, Chong Gao, Jinfang Zhao, Xiaofeng Li, Caihong Wang. Mediators Inflamm 2020
7
16

NK Cell Subtypes as Regulators of Autoimmune Liver Disease.
Guohui Jiao, Bangmao Wang. Gastroenterol Res Pract 2016
13
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.